17 alpha-hydroxylase deficiency epidemiology and demographics: Difference between revisions
(Created page with "__NOTOC__ {{Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Epidemiology and Demographics== ===Incidence=== *...") |
No edit summary |
||
| Line 10: | Line 10: | ||
===Age=== | ===Age=== | ||
* Patients of all age groups may develop congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. The mean age of diagnosis is infancy and childhood. | |||
===Gender=== | ===Gender=== | ||
Revision as of 14:55, 2 February 2016
|
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency epidemiology and demographics |
|
FDA on 17 alpha-hydroxylase deficiency epidemiology and demographics |
|
CDC on 17 alpha-hydroxylase deficiency epidemiology and demographics |
|
17 alpha-hydroxylase deficiency epidemiology and demographics in the news |
|
Blogs on 17 alpha-hydroxylase deficiency epidemiology and demographics |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Epidemiology and Demographics
Incidence
- The incidencee of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency in the United States is approximately 1 per 100,000 individuals.
Case Fatality Rate
Age
- Patients of all age groups may develop congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. The mean age of diagnosis is infancy and childhood.